Currently employed treatments for knee cartilage defects in the United States are cost-effective in most clinically acceptable applications. Microfracture is not a cost-effective initial treatment of defects >3 cm². OCA transplantation of the patella or bipolar lesions is potentially cost-ineffective and should be used judiciously.
No takes yet. Share an insight, caveat, or question.
Everhart et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: